Clinical trial
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot…
NCT00041171 · Alliance for Clinical Trials in Oncology, Other · Withdrawn
Key facts
| NCT number | NCT00041171 |
|---|---|
| Title | Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery |
| Official title | Phase III Randomized Study of Hypericum Perforatum (St. John's Wort) Combined With Docetaxel in Patients With Unresectable Solid Tumors |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Adult Solid Tumor, Breast Cancer, Head and Neck Cancer, Kidney and Urinary Cancer, Male Reproductive Cancer, Thorax and Respiratory Cancer |
| Intervention type | Drug, Other |
| Interventions | Hypericum perforatum, docetaxel, placebo |
| Enrollment | 0 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 12, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: